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Summary
Background A higher cognitive reserve and brain reserve could decrease mortality risk, but the interaction of these 
factors with general age-related loss of physical fitness (eg, frailty) remains unclear with regards to mortality. 
We investigated the associations of cognitive and brain reserve with mortality and the interaction of cognitive and 
brain reserve with frailty within these associations.
Methods Within the observational population-based cohort of the Rotterdam Study, we included participants who 
visited the research centre for a cognitive assessment between March 2, 2009, and March 1, 2012. Participants with an 
incomplete assessment of cognition, no data on education attainment, no MRI or an MRI of insufficient quality, 
three or more missing frailty criteria, or a dementia diagnosis were excluded. Participants were followed up until their 
death or May 1, 2019. Cognitive reserve was defined as a latent variable that captures variance across five cognitive 
tests. Brain reserve was defined as the proportion of healthy-appearing brain volume relative to total intracranial 
volume measured with 1·5 Tesla MRI. Frailty was defined according to Fried’s frailty phenotype; participants meeting 
at least one of the five criteria were considered frail. Hazard ratios (HRs) for associations of cognitive reserve, brain 
reserve, frailty, and reserve–frailty interactions with the risk of mortality were estimated using Cox regression models.
Findings 2878 individuals in the Rotterdam Study who visited the research centre for a cognitive assessment were 
considered eligible. 1388 individuals were excluded due to incomplete or missing data or a dementia diagnosis. 
1490 participants with valid information on cognitive reserve, brain reserve, and frailty were included (mean age 
74·3 years [SD 5·5]; 815 [55%] female participants). 810 (54%) participants were classified as frail. A higher cognitive 
reserve (HR 0∙87 per SD, 95% CI 0∙76–0∙99, p=0∙036) and a higher brain reserve (0∙85 per SD, 0∙72–1∙00, p=0∙048) 
were associated with a lower risk of mortality, after adjusting for sex, age, educational level, body-mass index, smoking 
status, and number of comorbidities. The association between cognitive reserve and mortality was more pronounced 
(0∙77 per SD, 0∙66–0∙90, p=0∙0012) when the cognitive reserve–frailty interaction (p=0∙0078) was included, 
indicating that higher cognitive reserve is related to lower mortality in individuals with frailty. The brain reserve–
frailty interaction was non-significant.
Interpretation Higher cognitive reserve and higher brain reserve were associated with a lower mortality risk. 
Additionally, cognitive reserve and frailty interact in the association with mortality, such that higher cognitive reserve 
is particularly associated with lower mortality in frail participants.
Funding Netherlands Organization for Health Research and Development and EU Horizon 2020 research programme.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 
license.
Introduction 
Age-related neuropathological damage can lead to 
clinical expression of brain diseases in some individuals 
and not in others. These differences in susceptibility to 
exhibiting clinical symptoms of neuropathology might 
be explained by cognitive reserve and brain reserve, 
which refer to individual differences in the functionality 
and structure of the brain.1 Cognitive reserve and brain 
reserve can act as moderators between neuropathology 
(eg, brain atrophy) and clinical symptoms related to that 
neuro pathology (eg, cognitive impairment). Coping 
mechanisms include greater network efficiency, capacity, 
or flexibility, or a higher number of neurons and 
synapses. Greater cognitive and brain reserve have been 
associated with beneficial health outcomes, in particular 
a reduced risk of dementia.2 Additionally, greater 
cognitive and brain reserve seem to be associated with a 
lower mortality risk, but it is unclear how physical health 
affects this association.3
Several proxies for cognitive and brain reserve have 
been investigated. The most commonly used proxy for 
cognitive reserve is educational attainment.1 Alternatively, 
a more detailed method was proposed to estimate 
cognitive reserve as a function of demographics, brain 
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pathology, and current level of cognition.4,5 Traditionally, 
proxies for brain reserve include gross whole brain 
measures, such as total intracranial volume.1 However, 
brain reserve has been hypothesised to be better indicated 
by more fine-grained measures, such as the proportion 
of healthy-appearing brain volume relative to total 
intracranial volume. Higher education and a greater 
proportion of healthy-appearing brain volume, corrected 
for intracranial volume, have both been associated with a 
lower risk of mortality,6,7 but for the more recently 
developed proxy of cognitive reserve, the association with 
mortality risk is unknown.
Cognitive and brain reserve might also interact with 
physical health to affect mortality risk. Physical health can 
be indicated by frailty, a condition characterised by age-
related deterioration in functional reserves across several 
physiological systems.3 Frailty is strongly associated with 
elevated mortality risk3 and often co-occurs with cognitive 
impairment or a reduced total brain volume.8,9 Whether 
frailty interacts with cognitive and brain reserve with 
regards to mortality is unknown. Previous literature 
investigating cognitive impairment, as opposed to 
cognitive reserve, suggests that cognitive impairment and 
frailty interact in their association with mortality,10 although 
a second study did not show this interaction in the 
association with mortality.11 Therefore, frailty might also 
interact with cognitive reserve in the association with 
mortality. For brain reserve, the interaction with frailty 
with regard to the association with mortality remains to be 
determined. In this population-based study of older adults 
we aimed to further elucidate the associations of cognitive 
and brain reserve with mortality risk and investigate the 




This study is part of the Rotterdam Study, a prospective 
population-based cohort including residents (aged 
≥45 years) of Rotterdam, Netherlands.12 Briefly, the 
original cohort started in 1990 and was expanded in 2000 
and 2006, leading to a total of 14 926 participants. 
Follow-up visits, consisting of a home interview and 
multiple visits to the research centre, occurred every 
3–6 years. Participants were additionally followed up via 
linkage with medical  and municipality records. For this 
study, eligible participants were those who visited the 
research centre for a cognitive assessment between 
March 2, 2009, and March 1, 2012. Participants were 
followed up until their death or May 1, 2019. Participants 
with three or more missing frailty criteria were excluded, 
and those with one or two missing frailty criteria were 
not excluded if they had at least three concordant positive 
or negative criteria. Participants were also excluded if 
their cognitive assessment was incomplete, no data on 
educational attainment were available, MRI data were 
not available or of insufficient quality, or they were 
diagnosed with prevalent dementia.
The Rotterdam Study was approved by the Medical 
Ethics Committee of the Erasmus MC University Medical 
Research in context
Evidence before this study
Several proxies of cognitive reserve, brain reserve, and frailty have 
previously been found to be risk factors for mortality. 
We searched PubMed using the search terms “frailty”, “cognitive 
reserve”, “cognitive impairment”, “brain reserve”, and “mortality” 
in relevant combinations, with no language restrictions, from 
database inception up to July 19, 2019. We found no studies that 
investigated the interaction of these factors with regards to 
mortality, although an interaction between cognitive or brain 
reserve and frailty, as an indicator of physical function, has been 
hypothesised. To the best of our knowledge, interaction of frailty 
with cognitive factors has been shown only for cognitive 
impairment and not for cognitive reserve. Additionally, studies 
over the past decade show that the methods used to estimate 
cognitive reserve have improved  by taking into account current 
cognitive function, brain pathology, and demographics. However, 
no studies have assessed the association with mortality using a 
newly developed proxy of cognitive reserve, which estimates 
cognitive reserve as a function of demographics, brain pathology, 
and current level of cognition.
Added value of this study
Our study confirms previously reported associations of 
cognitive reserve with mortality, with cognitive reserve 
estimated using a newly developed proxy that incorporates 
demographics, brain pathology, and current cognitive 
function. In addition, brain reserve and frailty were also 
associated with mortality in our population-based sample of 
older adults. Importantly, we also found an interaction of 
cognitive reserve and frailty in the association with mortality 
in older adults but found no interaction between brain 
reserve and frailty. These results further contribute to our 
understanding of the concepts of cognitive and brain reserve 
and their role in mortality.
Implications of all the available evidence
Together with previous literature, our results suggest that 
cognitive reserve, brain reserve, and frailty should be 
considered when researching methods to extend the life 
expectancy and healthy life-years of an individual. 
Additionally, the concepts of cognitive reserve and frailty 
interact, suggesting that they should be considered together 
and not independently. Although causality remains to be 
determined, we carefully infer that targeting cognitive 
reserve and frailty together might improve the early 
prevention of mortality and identification of those at high 
risk of mortality.
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Center (registration number MEC 02.1015) and by the 
Dutch Ministry of Health, Welfare and Sport (Population 
Screening Act WBO, licence number 1071272–159521-PG). 
The Rotterdam Study has been entered into the 
Netherlands National Trial Register and the WHO 
International Clinical Trials Registry Platform under the 
shared catalogue number NTR6831. All participants 
provided written informed consent to participate in the 
study and to have their information obtained from 
treating physicians. 
Procedures 
We estimated cognitive reserve using a structural 
equation model as described by Petkus and colleagues.4,13 
All participants completed a cognitive test battery at the 
research centre, including the Rey auditory verbal 
learning test, the Stroop task, the letter digit substitution 
task, the word fluency test, and the Purdue pegboard 
test.14 Cognitive reserve was defined as a latent variable 
that captures common variance across these five cognitive 
tests while adjusting for sociodemographic factors 
(age, sex, and educational level) and MRI-inferred 
neuropathological factors (total brain volume and white 
matter lesion volume). Educational attainment was 
assessed during the baseline interview and classified into 
four categories according to the UN Educational, 
Scientific and Cultural Organization classification: 
primary education (primary), lower or intermediate 
general education or lower vocational education (low), 
intermediate vocational education or higher education 
(intermediate), and higher vocational education or 
university (high). A higher cognitive reserve score 
therefore indicates better cognitive functioning than 
would be expected based on the individual’s age, sex, 
educational level, and MRI-inferred neuropathological 
factors.
Brain reserve was defined as the proportion of normal-
appearing brain volume (total brain volume minus white 
matter hyperintensity volume in cm³) relative to the total 
intracranial volume. To determine brain volumes at 
baseline, multi-sequence brain MRI was done on a 
1·5 Tesla MRI scanner with an eight-channel head coil 
(GE Signa Excite, GE Healthcare, Milwaukee, WI, USA). 
The scan and image processing protocol have been 
described previously.15 Briefly, images were automatically 
segmented into brain tissues using a computerised 
processing algorithm based on a k-nearest-neighbour 
classifier to classify voxels.16,17 The fluid-attenuated 
inversion recovery sequence was used to segment white 
matter lesions in order to estimate total white matter 
hyperintensity volume (in cm³). Total brain volume 
(in cm³) was computed by summing total grey and white 
matter, which included the white matter hyperintensity 
volumes. Intracranial volume (in cm³) was computed by 
summing the total brain and cerebrospinal fluid volume.
Frailty was operationalised using Fried’s frailty pheno-
type,18,19 which was designed in 2001 and is one of the most 
commonly used measures of frailty.20 Further details on 
the construction of frailty in the Rotterdam Study can be 
found elsewhere.19 Five criteria are used to define frailty: 
weight loss, exhaustion, low physical activity, weakness, 
and slow walking speed. Weight loss was defined as a 
decrease of more than 5% in body-mass index (obtained 
on calibrated scales) compared with the most recent 
previous examination at the research centre.19 Exhaustion 
was defined as answering “occasionally or a moderate 
amount of the time” or “most or all of the time” to at least 
one of two items in the Center for Epidemiological Studies 
Depression scale questionnaire:21 “I felt that everything I 
did was an effort” or “I could not get going”.18 Low physical 
activity was defined for women as expending fewer 
than 1130 kJ per week (<270 kcal per week) and for men as 
expending fewer than 1602 kJ per week (<383 kcal 
per week) on physical activity.18,22 Weakness was defined 
as poor grip strength measured on a handgrip dynamo-
meter (kg), using cutoffs stratified by sex and body-mass 
index.18 Slow walking speed (m/s) was measured with the 
GAITRite walkway (CIR Systems, Sparta, NJ, USA), using 
cutoffs stratified by sex and length.18 The number of criteria 
met was summed to indicate frailty. Frailty was defined as 
meeting three or more frailty criteria or meeting one or 
two criteria (also defined as pre-frail) because the number 
of participants meeting three or more criteria in our study 
was low (n=53). If participants did not meet any criteria, 
they were considered not frail.
Information on the vital status of participants was 
obtained on a weekly basis via municipal population 
registries and through general practitioners and medical 
records. All-cause mortality was defined as death 
from any cause during the total follow-up period (to 
May 1, 2019).
Smoking status was self-reported and categorised as 
never, former, or current smoker. Previously published 
guidelines were used to define hypertension, diabetes, 
osteoporosis, chronic obstructive pulmonary disease, 
kidney disease, heart failure, stroke, and cancer,19 based 
on measurements at our research centre and follow-up 
of medical records. For participants with complete data 
on all comorbidities, the total number of comorbidities 
was calculated.19 Ancestry was assessed by genotyping 
based on a blood draw; if these data were missing, 
self-reported ancestry was used.
Statistical analysis 
All continuous variables in the structural equation model 
were checked for normality and Z-score standardised. 
We log-transformed only white matter lesion volume 
before standardisation due to the skewed distribution. To 
estimate the cognitive reserve latent variable, the score 
from each cognitive test was regressed on age, sex, 
educational status, total brain volume, and log-transformed 
white matter lesion volume. Total brain volume and log-
transformed white matter lesion volume were adjusted for 
age, sex, and intracranial volume (appendix pp 2–3). Cutoff See Online for appendix
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values of comparative fit index greater than 0∙9, Tucker 
Lewis index greater than 0∙9, root-mean-square error of 
approximation of less than 0∙06, and standardised root 
mean square residual of less than 0∙08 were considered to 
indicate good model-data fit.23 The cognitive reserve latent 
variable was Z-score standardised. The structural equation 
model was built with the lavaan package in R 3.6.1.
To assess associations of cognitive reserve, brain 
reserve, and frailty with the risk of mortality we used Cox 
proportional hazard models. Start of follow-up was 
defined as the time of the last measurement of 
participants (ie, the date of MRI scan). The censor date 
was defined as the date of death, loss to follow-up, or 
May 1, 2019, whichever came first. Cognitive reserve and 
brain reserve were Z-standardised in all analyses. 
Associations of cognitive reserve, brain reserve, and 
frailty with the risk of mortality were analysed in three 
separate Cox regression models. In model 1, we adjusted 
only for age and sex. In model 2, we added additional 
confounding factors: body-mass index, smoking status, 
educational level, and the number of comorbidities. 
Ancestry was not considered as a confounder due to the 
homogeneity of the study population. In model 3a, we 
mutually adjusted cognitive reserve or brain reserve and 
frailty, meaning that cognitive and brain reserve, frailty, 
and all confounders were added to the model. 
In model 3b, we added cognitive reserve–frailty and 
brain reserve–frailty interaction terms to investigate 
multiplicative interaction. To calculate the interaction 
terms, we multiplied the variables of cognitive or brain 
reserve with frailty and included these variables in our 
model. Analyses comparing participants with no frailty 
or meeting one to two frailty criteria to those meeting 
three or more frailty criteria were done to assess 
whether the association of frailty with mortality was 
dose-dependent. Significant violation of the proportional 
hazard assumptions for all analyses was tested with the 
Schoenfeld residuals test. To visualise interactions, we 
created survival plots based on four strata using the 
median dichotomised cognitive and brain reserve 
and analysed the risk of mortality in each stratum. 
We additionally repeated analyses using educational 
attainment as a proxy for cognitive reserve, because this 
is a commonly used proxy for cognitive reserve and 
facilitates comparison with previous studies.
We did two sets of sensitivity analyses. First, we did 
additional analyses in which passive multiple imputation 
was used to determine frailty status, to account for 
missing data in frailty criteria. Second, we analysed the 
association between frailty, cognitive reserve, and brain 
reserve using frailty as a continuous variable to account 
for small group sizes.
Missing data on the number of comorbidities (0∙02%) 
were imputed five times using chained equations and the 
analyses were pooled across imputations. Results were 
summarised with hazard ratios (HRs) and 95% CIs. 
A p value of less than 0∙05 was considered statistically 
significant. All analyses were done in R 3.6.1.
Role of the funding source 
The funders had no role in the study design, data 
collection, data analysis, data interpretation, or writing of 
the report.
Results 
Between March 2, 2009, and March 1, 2012, 
2878 participants of the Rotterdam Study visited the 
Study participants (n=1490)

















Coronary disease 59 (4%)
Diabetes 104 (7%)
Osteoporosis 160 (11%)




Kidney disease 423 (28%)




Weight loss 277 (19%)
Exhaustion 186 (12%)
Low physical activity 44 (3%)
Weak grip strength 541 (36%)
Slow walking speed 29 (2%)
Frailty 810 (54%)
Reserve measure
Cognitive reserve† 0 (1)
Brain reserve 0∙78 (0∙04)
Data are n (%) or mean (SD). Data were missing for some participants for ancestry 
(n=4), anaemia (n=18), kidney disease (n=7), heart failure (n=6), weight loss 
(n=90), exhaustion (n=9), low physical activity (n=64), weak grip strength 
(n=22), and slow walking speed (n=313). *Assessed genetically (n=1293) or 
self-reported (n=197). †Z-score standardised.
Table 1: Baseline characteristics of the study population
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research centre for a cognitive assessment and were 
potentially eligible for inclusion in this study. 
1388 individuals were excluded because of incomplete 
cognitive assessments, no MRI or MRI of insufficient 
quality, incomplete frailty assessments, or having a 
dementia diagnosis. In total, 1490 participants with valid 
information on cognitive reserve, brain reserve, and 
frailty were included (appendix p 1).
At baseline, the mean age of participants was 74∙3 years 
(SD 5∙5); 815 (55%) of 1490 participants were female. 
810 (54%) participants were classified as frail (table 1). Of 
these participants, 53 met three or more frailty criteria and 
757 met one or two criteria (also defined as pre-frail). Of 
the five frailty criteria, weak grip strength was the most 
common (541 [37%] of 1467 participants). During the 
mean follow-up of 5·3 years (SD 1∙4), 214 (14%) of 
1490 participants died. The mean brain reserve was 0∙78 
(SD 0∙04). The structural equation model for cognitive 
reserve had a good model fit:23 comparative fit index 0∙99, 
Tucker Lewis index 0∙96, root-mean-squared error of 
approximation 0∙05 (90% CI 0∙03–0∙07), and standardised 
root mean square residual 0∙01. The cognitive reserve 
variable was Z-score standardised and therefore has a 
mean of 0 (SD 1). Participants were slightly younger, less 
often female, more educated, more often pre-frail, and had 
a lower brain reserve compared with participants who 
were excluded from the study (appendix p 4).
A higher cognitive reserve was associated with a lower 
risk of mortality after adjusting for all covariates and frailty 
(HR 0∙87 per SD, 95% CI 0∙76–0∙99, p=0∙035; table 2, 
model 3a). No frailty was also associated with a lower risk 
of mortality compared with frailty (0∙64, 0∙48–0∙86, 
p=0∙0029). This association between frailty and 
mortality risk was dose-dependent; when compared with 
participants meeting three or more criteria, those meeting 
one to two criteria had a lower mortality risk (0∙51, 
0∙32–0∙80, p=0∙0034) and those meeting no criteria had 
an even lower risk (0∙34, 0∙21–0∙56, p<0∙0001). After 
including the interaction term of cognitive reserve and 
frailty in the model (model 3b), a higher cognitive reserve 
was more strongly associated with a lower mortality risk 
(0∙77 per SD, 0∙66–0∙90, p=0∙0012). The interaction term 
was also associated with mortality risk (1∙48, 1∙11–1∙98, 
p=0∙0078), indicating that the association of cognitive 
reserve with mortality differs between those who are frail 
and those who are not frail. Stratified survival curves for 
the four groups split by the median cognitive reserve and 
frailty are shown in figure 1. Compared with frail 
participants with a low cognitive reserve, non-frail 
participants with either a low cognitive reserve (0∙54, 
0∙36–0∙82, p=0∙0042) or a high cognitive reserve (0∙58, 
0∙40–0∙86, p=0∙0066) had a lower risk of mortality. 
We found no significant differences between non-frail 
participants with a high or low cognitive reserve. Analyses 
using educational attainment as a proxy for cognitive 
reserve showed no significant associations with mortality, 
nor a significant interaction with frailty with regards to 
mortality risk (appendix p 5).
Higher brain reserve was associated with a lower risk 
of mortality, even after adjusting for all covariates 
(HR 0·83 per SD, 95% CI 0·70–0·97, p=0·024; table 3, 
model 2). However, when frailty was included (model 3a), 
the association between higher brain reserve and a lower 
risk of mortality was attenuated (0∙85 per SD, 0∙72–1∙00, 
p=0∙048). No frailty was associated with a lower risk of 
Model 1 Model 2 Model 3a Model 3b
HR (95% CI) p value HR (95% CI) p value HR (95% CI) p value HR (95% CI) p value
Cognitive reserve* 0∙86 (0∙75–0∙98) 0∙023 0∙86 (0∙76–0∙99) 0∙035 0∙87 (0∙76–0∙99) 0∙035 0∙77 (0∙66–0∙90) 0∙0012
Frailty status
Frail 1 (ref) ·· 1 (ref) ·· 1 (ref) ·· 1 (ref) ··
Not frail 0∙60 (0∙45–0∙80) 0∙0006 0∙64 (0∙48–0∙86) 0∙0029 0∙64 (0∙48–0∙86) 0∙0029 0∙65 (0∙48–0∙87) 0∙0053
In model 1, cognitive reserve and frailty were separately adjusted for age and sex. Model 2 had additional adjustment for educational level, body-mass index, smoking status, 
and number of comorbidities. In model 3a, cognitive reserve and frailty were also mutually adjusted. In model 3b, the cognitive reserve–frailty interaction term was included 
(pinteraction=0∙0078). HR=hazard ratio. *HRs are per SD increase.
Table 2: Cox proportional hazard models to estimate associations and interactions of cognitive reserve and frailty with the risk of mortality
Figure 1: Adjusted survival curves in groups stratified by frailty status and 
median cognitive reserve
Patients were classified as not frail, high cognitive reserve (n=352, 40 events); 
not frail, low cognitive reserve (n=328, 31 events); frail, high cognitive reserve 

























Not frail, high cognitive reserve
Not frail, low cognitive reserve
Frail, high cognitive reserve
Frail, low cognitive reserve
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mortality compared with frailty (0∙66, 0∙49–0∙88, 
p=0∙0056; table 3, model 3a). This association between 
frailty and mortality risk was dose-dependent; when 
compared with participants meeting three or more frailty 
criteria, those meeting one to two criteria had a lower 
mortality risk (0∙49, 0∙31–0∙77, p=0∙0022), and those 
meeting no criteria had an even lower risk (0∙34, 
0∙21–0∙57, p<0∙0001). The interaction between brain 
reserve and frailty was not associated with mortality 
(0∙90, 0∙66–1∙23, p=0∙55). Survival curves for the four 
groups split by the median brain reserve and frailty are 
shown in figure 2. Compared with frail participants with 
a low brain reserve, non-frail participants with either a 
low brain reserve (0∙70, 0∙49–0∙99, p=0∙048) or a high 
brain reserve (0∙51, 0∙32–0∙83, p=0∙0063) had a lower 
risk of mortality. We found no significant differences 
between participants without frailty with a high or low 
brain reserve.
Sensitivity analyses using passive multiple imputation 
to define the frailty status for those with one or 
two missing frailty criteria showed similar results for 
both cognitive and brain reserve (appendix p 6). 
Additionally, analyses using frailty as a continuous 
variable showed associations in a similar direction for 
both cognitive and brain reserve. These analyses should 
be interpreted with caution because residuals suggested 
a non-linear association that could not be improved 
by transformation of the continuous frailty score 
(appendix p 7).
Discussion 
In a population-based sample of older adults, we showed 
that higher cognitive and brain reserves were associated 
with a lower risk of mortality. We found that cognitive 
reserve and frailty interact in the association with 
mortality, such that cognitive reserve lowers the risk of 
mortality in individuals with frailty. We found no 
interaction between brain reserve and frailty in the 
association with mortality.
To date, the association between cognitive reserve and 
mortality has been investigated only by using educational 
level as a proxy for cognitive reserve. However, this proxy 
has several limitations because it might be influenced by 
sociodemographic and cultural factors.24,25 The static 
concept of highest attained educational level might not 
capture the dynamic nature of cognitive reserve well 
enough. Indeed, our analyses did not show an association 
between educational attainment and mortality. Using a 
more advanced method of estimating cognitive 
reserve,4,5 we show in this study that lower cognitive 
reserve increases mortality risk in community-dwelling 
older men and women. To date, the mechanisms 
underlying cognitive reserve and its association with 
mortality remain unknown. One hypothesis is that the 
brain uses pre-existing cognitive processing approaches 
or recruits compensatory approaches to cope with brain 
pathology.2 The association of cognitive reserve with lower 
mortality risk could be due to coping with cognitive 
decline,26 which is associated with an increased mortality 
risk.27 However, cognitive decline could also be 
symptomatic of dementia, non-dementia brain pathology, 
or systemic pathologies, such as metabolic imbalances, 
that can increase mortality risk.27
Additionally, our work suggests that cognitive reserve 
and frailty interact in the association with mortality. 
Figure 2: Adjusted survival curves in groups stratified by frailty and median 
brain reserve
Patients were classified as not frail, high brain reserve (n=412, 25 events); not 
frail, low brain reserve (n=268, 46 events); frail, high brain reserve (n=333, 

























Not frail, high brain reserve
Not frail, low brain reserve
Frail, high brain reserve
Frail, low brain reserve
Model 1 Model 2 Model 3a Model 3b
HR (95% CI) p value HR (95% CI) p value HR (95% CI) p value HR (95% CI) p value
Brain reserve* 0∙80 (0∙68–0∙93) 0∙0051 0∙83 (0∙70–0∙97) 0∙024 0∙85 (0∙72–1∙00) 0∙048 0∙87 (0∙72–1∙04) 0∙12
Frailty status
Frail 1 (ref) ∙∙ 1 (ref) ∙∙ 1 (ref) ∙∙ 1 (ref) ∙∙
Not frail 0∙60 (0∙45–0∙80) 0∙0006 0∙64 (0∙48–0∙86) 0∙0029 0∙66 (0∙49–0∙88) 0∙0056 0∙63 (0∙46–0∙87) 0∙0053
In model 1, brain reserve and frailty were separately adjusted for age and sex. Model 2 had additional adjustment for educational level, body-mass index, smoking status, and 
number of comorbidities. In model 3a, brain reserve and frailty were also mutually adjusted. In model 3b, the brain reserve–frailty interaction term was included 
(pinteraction=0∙55). HR=hazard ratio. *HRs are per SD increase.
Table 3: Cox proportional hazard models to estimate associations and interactions of brain reserve and frailty with the risk of mortality
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Two previous studies have investigated the interaction 
between cognitive impairment and frailty in the association 
with mortality.10,11 Cognitive impairment is suggested to be 
inversely related to the concept of cognitive reserve and 
underlying mechanisms might differ. Although our 
measure is designed to capture cognitive reserve, it is 
possible that a low cognitive reserve at least partly captures 
cognitive impairment. Interaction of cognitive impairment 
and frailty was observed in a study of 11 266 individuals, 
which found that cognitive impairment at baseline 
moderated the effect of frailty on mortality over 3 years of 
follow-up.10 However, a second study (n=1751) with 5 years 
of follow-up found no interaction between frailty 
and cognitive impairment in predicting mortality.11 
Studies investigating frailty and cognitive impairment 
suggest that hormonal dysregulation, insulin resistance, 
sarcopenia, nutritional deficiency, chronic inflammation, 
cardiovascular risks, and depression are underlying factors 
in the interaction between cognitive impairment and 
frailty.28 Whether similar mechanisms are involved in the 
interaction between cognitive reserve and frailty remains 
to be determined.
In our study, a higher brain reserve was associated 
with a lower risk of mortality. Previous research found 
similar associations between brain volume corrected for 
intracranial volume and mortality.7,29 The association in 
our study was attenuated when adjusted for frailty status. 
Because frailty is a measure of loss of functional reserve 
across multiple physiological systems, it could possibly 
also affect brain reserve. We defined brain reserve as the 
proportion of healthy-appearing brain volume relative to 
total intracranial volume, as opposed to intracranial 
volume itself, to take into account dynamic changes of 
brain reserve. We excluded participants with dementia 
so that our approach was likely to distinguish the 
structural characteristics of brain reserve from the 
neuropathological volume loss secondary to dementia.1 
Mechanisms underlying brain reserve are largely 
unclear. Initially, brain reserve was only hypothesised to 
be quantitative, such that a brain with more neurons or 
synapses has more to lose. However, it might be more 
nuanced; for example, stimulating environments 
promote neurogenesis and upregulate brain-derived 
neurotrophic factor, which promotes neuroplasticity.2 
Brain reserve is possibly associated with mortality by 
limiting global atrophy, which has been associated with 
mortality.29 A higher brain reserve could also lower 
mortality risk by lowering the risk of Alzheimer’s 
disease,13 other dementias, and non-dementia brain 
pathology that can increase the risk of mortality.
Causality remains to be determined, but we carefully 
infer that targeting cognitive reserve and frailty might 
help in the early prevention of mortality and identification 
of those at high risk of mortality. Our study also shows 
that these concepts should be considered together, 
instead of as independent issues. Further research is 
needed to determine whether novel strategies or 
therapies could improve cognitive reserve and physical 
functioning in individuals with frailty, and whether these 
therapies could extend healthy life-years. However, we do 
not yet know whether frailty affects the association of 
cognitive reserve with mortality or, vice versa, whether 
cognitive reserve affects the association of frailty with 
mortality.
A limitation of our measure of cognitive reserve is 
that the associations in the structural equation model 
might lack unknown brain variables and non-linear 
associations or interactions that have a role in cognitive 
reserve, possibly biasing our estimate.4 Additionally, 
weight loss was based on examinations during centre 
visits and did not take into account whether it was 
unintentional or not,18 which could have led to a dilution 
of the association. Certain criteria could be more 
significant than others when defining frailty, which 
needs to be studied further. For all self-reported 
variables (eg, smoking), self-reporting bias is possible. 
Further bias might have been introduced by excluding 
persons who did not have complete data, with missing 
data probably not missing completely at random. 
Because all variables were collected at baseline, a change 
of comorbidities during the follow-up of this study 
could bias the associations. Our study was done in a 
Dutch, largely Caucasian, population-based sample of 
older people, and generalising these results to other 
groups should be done with caution. Although our 
results were in line with a larger study investigating the 
interaction between frailty and cognitive impairment in 
a sample of 11 266 community-dwelling Koreans aged 
65 years and older,10 further research investigating 
cognitive reserve in other groups is required to ensure 
the current findings are generalisable. The strengths of 
our study are the prospective cohort design, making it 
less prone to information and selection bias, and the 
large sample size of the population.
In conclusion, a higher cognitive reserve seems to 
particularly protect against mortality in individuals with 
physical frailty. A higher brain reserve is associated with 
a lower risk of mortality in both frail and not frail 
individuals. Considering cognitive reserve as well as 
frailty might help in the early prevention of mortality and 
identification of those at high risk of mortality. Strategies 
or novel therapies that support cognitive and physical 
functioning might help to extend healthy life-years.
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